سعر لوتون 25 مجم / 1 مل 3 امبول 2024

Lutone progesterone 25 mg/ml solution for intramuscular injection, 3 ampoules, by Misr (Egypt).

• Amenorrhoea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology (US indication for progesterone 50 mg/mL injection; Egyptian Lutone indications not seen).Population: WomenDailyMed (U.S. National Library of Medicine)

• Breakthrough bleeding, spotting, change in menstrual flow, amenorrhoea, oedema, weight change, cholestatic jaundice, breast tenderness, injection-site pain or redness, urticaria/rash, acne, alopecia, hirsutism, anaphylactoid reactions, depression, fever, insomnia, nausea and somnolence.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Current or past thrombophlebitis, thromboembolic disorders or cerebral apoplexy; liver dysfunction or disease; known or suspected breast or genital malignancy; undiagnosed vaginal bleeding; missed abortion; known sensitivity to progesterone injection.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Discontinue immediately at the earliest signs of thrombotic disorders (thrombophlebitis, cerebrovascular disorders, pulmonary embolism, retinal thrombosis).General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Stop pending examination if sudden partial or complete loss of vision, proptosis, diplopia or migraine occurs; withdraw if papilloedema or retinal vascular lesions are found.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Ketoconazole and other CYP3A4 inhibitorsInhibit progesterone metabolism in vitro and may increase its bioavailability; clinical relevance unknown.DailyMed (U.S. National Library of Medicine)

• Detectable amounts of progestational drugs have been found in breast milk; the effect on the nursing infant is not known.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Progesterone: Transforms proliferative endometrium into secretory endometrium and, at usual doses, inhibits pituitary gonadotropin secretion (US progesterone injection label, ingredient level).